ДОЛГ Изменить Дата
AbbVie USD 70.82B 2.04B 2026-06
Alcon AG USD 5.3B 43M 2026-06
Almirall EUR 356.11M 13.25M 2026-06
Amgen USD 57.3B 19M 2026-06
argenx SE USD 47M 160K 2026-06
AstraZeneca USD 32.24B 1.68B 2026-06
Autolus Therapeutics Ltd USD 253.44M 8.84M 2025-03
Bayer EUR 36.45B 2.93B 2025-12
Biogen USD 7.69B 398.3M 2026-09
Bristol-Myers Squibb USD 42.88B 2.18B 2026-09
Eli Lilly USD 54.91B 11.54B 2026-06
Fresenius EUR 11.42B 488M 2026-06
Fresenius Medical Care EUR 10.89B 76.86M 2026-09
Genmab DKK 5.35B 5.2B 2026-03
Gilead Sciences USD 26.25B 4.07B 2026-06
GlaxoSmithKline GBP 18.24B 818M 2026-06
GRIFOLS EUR 9.24B 723M 2026-09
Haleon GBP 8.58B 130M 2025-12
Hikma Pharmaceutical USD 1.6B 46M 2025-12
Lakefront Biotherapeutics EUR 6.44M 480K 2026-03
Lonza CHF 4.71B 915M 2024-12
Merck EUR 12.3B 264M 2026-06
Merck USD 53.91B 4.79B 2026-06
Novartis USD 49.01B 2.02B 2026-06
Orion EUR 125.5M 204.8M 2026-09
Pfizer USD 62.67B 523M 2026-09
Philips EUR 8.14B 674M 2026-09
Recordati EUR 2.31B 57.06M 2026-06
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 23.58B 3.56B 2026-06
UCB EUR 3.03B 12M 2024-12